Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:26 AM
Ignite Modification Date:
2025-12-25 @ 2:26 AM
NCT ID:
NCT03545334
Eligibility Criteria:
Inclusion Criteria:
* Malignant melanoma patients having one of the following characteristics:
* Breslow score ≥ 1 mm
* Breslow score ≥ 0.7 mm associated with ulceration
* Breslow score ≥ 0.7 mm associated with regression
* Breslow score ≥ 0.7 mm associated with Clark Level IV / V
* Breslow score ≥ 0.7 mm associated with mitotic rate ≥ 1/mm2 in young patients
* Merkel cell carcinoma
Exclusion Criteria:
* Age \< 18 years
* Pregnancy and breastfeeding (pregnancy test to be performed for women of child-bearing potential, defined as women who are not surgically sterilized/ hysterectomized, and/or who are postmenopausal for less than 12 months)
* Known allergy to ICG or Iodine
* Previous chemotherapy, radiotherapy or surgery to the lymph nodes of interest
* Lack of capacity to provide informed consent
* Current enrolment in any other interventional study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03545334
Study Brief:
Protocol Section:
NCT03545334